CN113694132A - Medicine for treating scald and its preparing method - Google Patents
Medicine for treating scald and its preparing method Download PDFInfo
- Publication number
- CN113694132A CN113694132A CN202111141808.8A CN202111141808A CN113694132A CN 113694132 A CN113694132 A CN 113694132A CN 202111141808 A CN202111141808 A CN 202111141808A CN 113694132 A CN113694132 A CN 113694132A
- Authority
- CN
- China
- Prior art keywords
- parts
- reaction tank
- medicine
- radix
- radix aconiti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 40
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 229940079593 drug Drugs 0.000 title description 8
- 238000000034 method Methods 0.000 title description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 45
- 244000173853 Sanguisorba officinalis Species 0.000 claims abstract description 19
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 19
- 241000913745 Spatholobus Species 0.000 claims abstract description 18
- 238000001816 cooling Methods 0.000 claims abstract description 14
- 238000010438 heat treatment Methods 0.000 claims abstract description 14
- 238000003756 stirring Methods 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 240000004980 Rheum officinale Species 0.000 claims abstract description 8
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 8
- 238000009835 boiling Methods 0.000 claims abstract description 8
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 7
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 240000000031 Achyranthes bidentata Species 0.000 claims abstract description 7
- 241000218671 Ephedra Species 0.000 claims abstract description 7
- 229940116229 borneol Drugs 0.000 claims abstract description 7
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 7
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000000227 grinding Methods 0.000 claims abstract description 7
- 238000007873 sieving Methods 0.000 claims abstract description 7
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 6
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 6
- 241000243684 Lumbricus Species 0.000 claims abstract description 6
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 6
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 14
- 241000219061 Rheum Species 0.000 claims description 11
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 6
- 241000213006 Angelica dahurica Species 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 25
- 238000002360 preparation method Methods 0.000 abstract description 9
- 231100000241 scar Toxicity 0.000 abstract description 7
- 238000005520 cutting process Methods 0.000 abstract description 4
- 230000004044 response Effects 0.000 abstract description 3
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 19
- 206010052428 Wound Diseases 0.000 description 17
- 208000002193 Pain Diseases 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000032544 Cicatrix Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000037387 scars Effects 0.000 description 4
- 241000227129 Aconitum Species 0.000 description 3
- 241000173529 Aconitum napellus Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000935235 Fritillaria meleagris Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 206010006802 Burns second degree Diseases 0.000 description 1
- 206010006803 Burns third degree Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000010891 electric arc Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000009416 jing wan hong Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The medicine for treating the scalds comprises the following components in parts by weight: 3-15 parts of rheum officinale, 9-27 parts of sanguisorba officinalis, 5-15 parts of suberect spatholobus stem, 15-45 parts of earthworm, 14-42 parts of achyranthes bidentata, 4-12 parts of angelica sinensis, 6-18 parts of bulbus fritilariae, 7-21 parts of cassia twig, 13-39 parts of ephedra, 6-18 parts of dark plum, 16-48 parts of raw radix aconiti, 17-51 parts of raw radix aconiti agrestis and 3.3-10 parts of borneol. The preparation method comprises the following steps: grinding radix et rhizoma Rhei, radix Sangusorbae and caulis Spatholobi, sieving, adding water, boiling for 5-10 min; cooling, grinding and sieving Lumbricus, Achyranthis radix, radix Angelicae sinensis, Bulbus Fritillariae Cirrhosae, ramulus Cinnamomi, herba Ephedrae and mume fructus, pouring into a reaction tank, stirring at 150 deg.C for 10-30 min, stopping heating, cutting radix Aconiti and radix Aconiti Kusnezoffii, adding, and stirring for 10-20 min; and finally cooling and filtering the residues. The scald medicine has good effect on I-degree and II-degree scalds or burns, and has good curative effect, quick response and difficult scar remaining.
Description
Technical Field
The invention relates to a medicine for treating scald and a preparation method thereof
Background
Burn and scald are the changes of human tissues caused by high temperature objects or heat radiation, and the causes of the burn and scald include flame, hot iron, boiling oil, boiled water, soup, electric arc, chemical substances and the like. The degree of injury is divided into four degrees from the pathological perspective, the first degree: blood is engorged by paralysis of blood vessels. And a second degree: forming a serum-filled burn blister. And a third degree: the tissue is necrotic. And fourth degree: charring the tissue; from the clinical dialectical point of view, three degrees are distinguished, namely: redness, pain, or significant tenderness, exudate or edema of the skin, but no blisters, is I degrees. The skin is blister, the bottom of blister is red or white, and is filled with clear and viscous liquid, and the blister is tender and sensitive, and becomes white at II degrees when being pressed. The skin surface is whitish, softened, and burst, or black, carbonized, and leather-like. It is noted that the third degree burn area is generally not painful as the skin is burned, because the nerve endings are damaged, but the necrotic tissue is erosive after several days, so several days often pass after the burn to distinguish deep second degree from third degree burns.
The existing medicines for treating burns have many functions, such as the functions of western medicines, namely inflammation diminishing, antibiosis and pain relieving, but the existing medicines have some defects, such as: has certain toxic and side effects, poor regeneration capability of promoting skin tissues of the wound surface of deep burn, undesirable effects of resisting infection and treating edema after burn and high price. Some traditional Chinese medicine burn ointments such as Jingwanhong, scald and fire wound infiltrating ointment, Meibao and the like represent Meibao, have obvious curative effect, but are only suitable for exposure therapy, and bring great inconvenience to life after the exposure therapy is used for patients with large area and trunk and four limbs because secretion of wound surfaces needs to be scraped for many times during use, so that patients feel painful. Some powder medicines are prepared by crushing and blending traditional Chinese medicines and then directly applying the traditional Chinese medicines on the wound surface, and granular traditional Chinese medicines can cause inflammatory reaction of the wound surface, so that the powder medicines have the defects of complicated use, slow absorption, poor effect and the like. In addition, the existing external-use burn medicine can only be applied to burns and scalds generally, and is not applicable to external wounds and some wounds after operation.
Disclosure of Invention
The invention aims to solve the first technical problem of providing a medicine for treating scald, which has the functions of clearing heat and removing toxicity, has good effect on I-degree and II-degree scalds or burns, has good curative effect and quick response, can stop bleeding and relieve pain, and is not easy to scar after wound healing.
The second technical problem to be solved by the invention is to provide the preparation method of the medicine for treating scald, which has the advantages of simple steps, convenient and quick preparation process and low cost.
In order to solve the first technical problem, the invention provides a medicine for treating scald, which comprises the following components in parts by weight: 3-15 parts of rheum officinale, 9-27 parts of sanguisorba officinalis, 5-15 parts of suberect spatholobus stem, 15-45 parts of earthworm, 14-42 parts of achyranthes bidentata, 4-12 parts of Chinese angelica, 6-18 parts of bulbus fritilariae, 7-21 parts of cassia twig, 13-39 parts of ephedra, 6-18 parts of dark plum fruit, 16-48 parts of raw radix aconiti, 17-51 parts of raw radix aconiti agrestis and 3.3-10 parts of borneol.
The rhubarb has the effects of purging and eliminating accumulation, clearing heat and purging fire, cooling blood and detoxifying, removing stasis and stimulating the menstrual flow, promoting diuresis and removing jaundice, and is used for treating excess heat constipation, delirium and head-end syndrome, food stagnation and fullness, dysentery onset, tenesmus, stasis and amenorrhea, abdominal mass, occasional heat epidemic, acute red and painful eyes, hematemesis, epistaxis, yang jaundice, edema, stranguria with turbid urine, carbuncle and ulcer pyogenic infections, furuncle and fire injury.
The garden burnet is cold in nature, bitter in acid in taste and non-toxic; it enters liver, lung, kidney and large intestine meridians. Has effects in cooling blood, stopping bleeding, relieving swelling and pain, clearing away heat and toxic materials, nourishing yin, and promoting wound healing.
Caulis Spatholobi is traditional Chinese medicine for promoting blood circulation and replenishing blood, and has effects of dispelling pathogenic wind and promoting blood circulation, relieving rigidity of muscles and activating collaterals, promoting blood circulation and removing blood stasis, regulating menstruation and relieving pain. Is a commonly used herb for treating the syndrome of unsmooth meridians and collaterals.
Di Long has the actions of relieving diarrhea due to salty cold, and moving with nature, and can extinguish wind and stop spasm, clear and resolve high fever, unblock meridians and activate collaterals.
The achyranthes bidentata picric acid, neutral in nature, enters liver and kidney meridians, and has the effects of promoting blood circulation, stimulating menstrual flow, nourishing liver and kidney, strengthening tendons and bones, inducing diuresis, treating stranguria and inducing fire (blood) to descend.
Dang Gui is sweet in flavor and warm in nature. Has effects in nourishing blood, regulating menstruation, relieving pain, moistening dryness, smoothing intestine, and treating blood deficiency, and can be used for treating numbness of skin, constipation, dysentery, carbuncle, skin ulcer, traumatic injury, cancer, aging, and immunity.
Bulbus Fritillariae Cirrhosae has antitussive, expectorant, and blood pressure lowering effects, and has antibacterial effect.
Ramulus Cinnamomi has effects of inducing sweat, expelling pathogenic factors from muscles, warming and dredging channels, tonifying yang, regulating qi, and calming the adverse-rising energy.
The ephedra herb is warm in nature, pungent and slightly bitter in taste, and has the effects of sweating, dispelling cold, ventilating and smoothing lung, relieving asthma, inducing diuresis and reducing edema.
The dark plum has the effects of astringing lung, astringing intestine, promoting fluid production and calming ascaris.
Radix Aconiti has effects of dispelling pathogenic wind, removing dampness, warming channels and relieving pain.
The radix Aconiti Kusnezoffii has effects of dispelling pathogenic wind and removing dampness, warming channels for dispelling cold, and relieving swelling and pain.
Borneol is pungent, bitter and slightly cold. It enters heart, spleen and lung meridians. The product has effects of inducing resuscitation, refreshing mind, clearing heat, removing toxic substance, improving eyesight, and removing nebula, and can be used for treating fever, hyperpyrexia, coma, apoplexy, phlegm syncope, convulsion, summer-heat dampness covering resuscitation, pharyngitis, deafness, aphtha, swelling of teeth, skin ulcer, carbuncle, malnutritional hemorrhoid, conjunctival congestion, swelling and pain, nebula, and eye covering.
For the sake of simplicity of explanation, the scald medicines of the present invention are simply referred to as "present scald medicine" below.
The application method of the medicine for treating scald comprises the following steps: the medicinal balm for treating scald is mixed with oleum Sesami, and then applied to the affected part of scald or burn for 1-2 times per day, generally for one week. Scratching wounds are prohibited during medication, and the scald or burn reaching the III degree is recommended to be treated in a hospital and then repaired by the scald medicament.
The medicament for treating the scald has the advantages that: the medicine for treating scald has the advantages of clearing heat and removing toxicity, having good effect on I-degree and II-degree scalds or burns, good curative effect and quick response, generally eliminating discomfort caused by the burns and the scalds within 3-7 days, stopping bleeding and relieving pain, repairing skin tissues of the wounds and not easily leaving scars after the wounds are healed.
The product has obvious curative effect on scald or burn, and also has good hemostatic and analgesic effects on wounds such as incised wound and bruise, and the wound can be quickly repaired by using the product, so that the effect is quick. It also has obvious itching relieving and swelling eliminating effects on eczema and chilblain.
The scald medicine has wide application range and low price, and is favorable for popularization.
The curative effect evidence is as follows:
case one: the patient male is 12 years old, the hand is scalded by boiling water in the kettle, the I-degree scald is diagnosed, the scald medicine is smeared, and the scald medicine is cured after five days without scars.
Case two: when a female is 28 years old and dishes are fried, the face of the female is splashed with oil, the scald part is soaked in water and the water bubble is broken due to the careless touch of the female, after the treatment in a hospital, the scald medicine is continuously used for repairing and treating the female, the female is cured for seven days, and scars are not left.
Case three: a male patient aged 40 years old is burnt by splashed glass molten slurry during working by workers in a glass production workshop, a wound is festered and oozed, the scald medicine is immediately smeared after the wound is treated, and the male patient is cured in ten days without scars.
Case four: the patient is 16 years old, the forehead part is not scratched by a eyebrow knife, the wound is deep, bleeding is accompanied, the hemostasis is completed within 90 seconds after the scald medicine is smeared, and the wound is cured and has no scar after one week.
In order to solve the second technical problem, the invention provides a preparation method of a medicine for treating scald, which comprises the following steps:
(1) crushing and grinding the rhubarb, the garden burnet and the suberect spatholobus stem respectively by a ball mill, then filtering the crushed and ground rhubarb, the garden burnet and the suberect spatholobus stem by a filter screen of 100 meshes and 200 meshes, then pouring the crushed and ground rhubarb, the garden burnet and the suberect spatholobus stem into a reaction tank, adding water into the reaction tank, boiling the mixture, and simultaneously stirring the solution in the reaction tank at a constant speed for 5 to 10 minutes;
(2) stopping heating the liquid in the reaction tank, naturally cooling to 70-80 deg.C, pulverizing Lumbricus, Achyranthis radix, radix Angelicae sinensis, Bulbus Fritillariae Cirrhosae, ramulus Cinnamomi, herba Ephedrae and mume fructus respectively in sequence by ball mill, sieving with 50-100 mesh filter screen, and pouring into the reaction tank;
(3) heating the reaction tank to the temperature of 130-;
(4) and cooling the liquid in the reaction tank to normal temperature, and filtering residues.
The method has simple steps, convenient and quick preparation process and low cost.
Detailed Description
The first embodiment is as follows:
the medicine for treating the scalds comprises the following components in parts by weight: 3 parts of rhubarb, 9 parts of garden burnet root, 5 parts of suberect spatholobus stem, 15 parts of earthworm, 14 parts of achyranthes bidentata, 4 parts of Chinese angelica, 6 parts of tendril-leaved fritillary bulb, 7 parts of cassia twig, 13 parts of ephedra, 6 parts of dark plum fruit, 16 parts of raw common monkshood mother root, 17 parts of raw kusnezoff monkshood root and 3.3 parts of borneol.
The preparation method comprises the following steps:
(1) respectively crushing and grinding rheum officinale, garden burnet and suberect spatholobus stem by using a ball mill, then filtering the ground rheum officinale, garden burnet and suberect spatholobus stem by using a filter screen of 100 meshes, pouring the ground rheum officinale, garden burnet and suberect spatholobus stem into a reaction tank, adding water into the reaction tank, boiling the mixture, and simultaneously stirring the solution in the reaction tank at a constant speed for 5 minutes;
(2) stopping heating the liquid in the reaction tank, naturally cooling to 70 deg.C, pulverizing Lumbricus, Achyranthis radix, radix Angelicae sinensis, Bulbus Fritillariae Cirrhosae, ramulus Cinnamomi, herba Ephedrae and mume fructus respectively in sequence by ball mill, sieving with 50 mesh filter screen, and pouring into the reaction tank;
(3) heating the reaction tank to 130 ℃, simultaneously stirring the liquid in the reaction tank at a constant speed for 10 minutes, then stopping heating the reaction tank, cutting the raw radix aconiti and the raw radix aconiti agrestis into pieces, pouring the cut pieces into the reaction tank, and continuously stirring for 10 minutes;
(4) and cooling the liquid in the reaction tank to normal temperature, and filtering residues.
Example two:
the medicine for treating the scalds comprises the following components in parts by weight: 9 parts of rhubarb, 18 parts of garden burnet root, 10 parts of suberect spatholobus stem, 30 parts of earthworm, 28 parts of achyranthes bidentata, 8 parts of Chinese angelica, 12 parts of tendril-leaved fritillary bulb, 14 parts of cassia twig, 26 parts of ephedra, 12 parts of dark plum fruit, 32 parts of raw common monkshood mother root, 34 parts of raw kusnezoff monkshood root and 6.6 parts of borneol.
The preparation method comprises the following steps:
(1) respectively crushing and grinding the rhubarb, the garden burnet and the suberect spatholobus stem by a ball mill, then filtering the crushed materials by a filter screen of 150 meshes, pouring the crushed materials into a reaction tank, adding water into the reaction tank, boiling the mixture, and simultaneously stirring the solution in the reaction tank at a constant speed for 7.5 minutes;
(2) stopping heating the liquid in the reaction tank, naturally cooling to 75 deg.C, pulverizing Lumbricus, Achyranthis radix, radix Angelicae sinensis, Bulbus Fritillariae Cirrhosae, ramulus Cinnamomi, herba Ephedrae and mume fructus respectively in sequence by ball mill, sieving with 150 mesh filter screen, and pouring into the reaction tank;
(3) heating the reaction tank to 140 ℃, simultaneously stirring the liquid in the reaction tank at a constant speed for 20 minutes, stopping heating the reaction tank, cutting the raw radix aconiti and the raw radix aconiti agrestis into pieces, pouring the cut raw radix aconiti and the raw radix aconiti agrestis into the reaction tank, and continuously stirring for 15 minutes;
(4) and cooling the liquid in the reaction tank to normal temperature, and filtering residues.
Example three:
the medicine for treating the scalds comprises the following components in parts by weight: 15 parts of rhubarb, 27 parts of garden burnet root, 15 parts of suberect spatholobus stem, 45 parts of earthworm, 42 parts of achyranthes bidentata, 12 parts of Chinese angelica, 18 parts of tendril-leaved fritillary bulb, 21 parts of cassia twig, 13-39 parts of ephedra, 18 parts of dark plum fruit, 48 parts of raw common monkshood mother root, 51 parts of raw kusnezoff monkshood root and 10 parts of borneol.
The preparation method comprises the following steps:
(1) respectively crushing and grinding rheum officinale, garden burnet and suberect spatholobus stem by using a ball mill, then filtering the ground rheum officinale, garden burnet and suberect spatholobus stem by using a 200-mesh filter screen, pouring the mixture into a reaction tank, adding water into the reaction tank, boiling the mixture, and simultaneously stirring the solution in the reaction tank at a constant speed for 10 minutes;
(2) stopping heating the liquid in the reaction tank, naturally cooling to 80 deg.C, pulverizing Lumbricus, Achyranthis radix, radix Angelicae sinensis, Bulbus Fritillariae Cirrhosae, ramulus Cinnamomi, herba Ephedrae and mume fructus respectively in sequence by ball mill, sieving with 100 mesh filter screen, and pouring into the reaction tank;
(3) heating the reaction tank to 150 ℃, simultaneously stirring the liquid in the reaction tank at a constant speed for 30 minutes, then stopping heating the reaction tank, cutting the raw radix aconiti and the raw radix aconiti agrestis into pieces, pouring the cut pieces into the reaction tank, and continuously stirring for 20 minutes;
(4) and cooling the liquid in the reaction tank to normal temperature, and filtering residues.
Claims (2)
1. The medicine for treating scalds is characterized by comprising the following components in parts by weight: 3-15 parts of rheum officinale, 9-27 parts of sanguisorba officinalis, 5-15 parts of suberect spatholobus stem, 15-45 parts of earthworm, 14-42 parts of achyranthes bidentata, 4-12 parts of Chinese angelica, 6-18 parts of bulbus fritilariae, 7-21 parts of cassia twig, 13-39 parts of ephedra, 6-18 parts of dark plum fruit, 16-48 parts of raw radix aconiti, 17-51 parts of raw radix aconiti agrestis and 3.3-10 parts of borneol.
2. The method for producing a medicine for treating scald as defined in claim 1, comprising the steps of:
(1) crushing and grinding the rhubarb, the garden burnet and the suberect spatholobus stem respectively by a ball mill, then filtering the crushed and ground rhubarb, the garden burnet and the suberect spatholobus stem by a filter screen of 100 meshes and 200 meshes, then pouring the crushed and ground rhubarb, the garden burnet and the suberect spatholobus stem into a reaction tank, adding water into the reaction tank, boiling the mixture, and simultaneously stirring the solution in the reaction tank at a constant speed for 5 to 10 minutes;
(2) stopping heating the liquid in the reaction tank, naturally cooling to 70-80 deg.C, pulverizing Lumbricus, Achyranthis radix, radix Angelicae sinensis, Bulbus Fritillariae Cirrhosae, ramulus Cinnamomi, herba Ephedrae and mume fructus respectively in sequence by ball mill, sieving with 50-100 mesh filter screen, and pouring into the reaction tank;
(3) heating the reaction tank to the temperature of 130-;
(4) and cooling the liquid in the reaction tank to normal temperature, and filtering residues.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111141808.8A CN113694132A (en) | 2021-09-28 | 2021-09-28 | Medicine for treating scald and its preparing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111141808.8A CN113694132A (en) | 2021-09-28 | 2021-09-28 | Medicine for treating scald and its preparing method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113694132A true CN113694132A (en) | 2021-11-26 |
Family
ID=78662195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111141808.8A Pending CN113694132A (en) | 2021-09-28 | 2021-09-28 | Medicine for treating scald and its preparing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113694132A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103272040A (en) * | 2013-05-31 | 2013-09-04 | 刘建飞 | Burn and scald treatment medicine |
CN106728793A (en) * | 2017-03-18 | 2017-05-31 | 张家界湘西豪猪生态农业旅游发展有限公司 | A kind of porcupine oil medicament for treating empyrosis and skin erosion |
CN108686019A (en) * | 2018-07-30 | 2018-10-23 | 佛山科学技术学院 | A kind of Chinese medicine external ointment for treating scald and preparation method thereof |
CN110522837A (en) * | 2019-09-23 | 2019-12-03 | 李兴夫 | A kind of medicament for treating scald |
-
2021
- 2021-09-28 CN CN202111141808.8A patent/CN113694132A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103272040A (en) * | 2013-05-31 | 2013-09-04 | 刘建飞 | Burn and scald treatment medicine |
CN106728793A (en) * | 2017-03-18 | 2017-05-31 | 张家界湘西豪猪生态农业旅游发展有限公司 | A kind of porcupine oil medicament for treating empyrosis and skin erosion |
CN108686019A (en) * | 2018-07-30 | 2018-10-23 | 佛山科学技术学院 | A kind of Chinese medicine external ointment for treating scald and preparation method thereof |
CN110522837A (en) * | 2019-09-23 | 2019-12-03 | 李兴夫 | A kind of medicament for treating scald |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104001034A (en) | Chinese herbal medicine ointment for treating burns and scalds | |
CN102552501B (en) | External traditional Chinese medicine composition for treating leukoplakia vulvae | |
CN107184782A (en) | External medicine composition, preparation method and applications | |
CN102579920B (en) | Chinese medicine ointment for curing human-body scars and preparation method thereof | |
CN101164604B (en) | Traditional Chinese medicine for treating arthrosis and preparing method thereof | |
CN102119975B (en) | Chinese herbal medicine ointment for treating ulcer, bedsore and vascular dermatoses | |
CN103845578A (en) | External tincture for treating burns, bedsore and herpes zoster and preparation method thereof | |
CN104027483B (en) | Traditional Chinese medicine ointment for treating burn and scald and preparation method thereof | |
CN113694132A (en) | Medicine for treating scald and its preparing method | |
CN103977367A (en) | Traditional Chinese medicament for treating qi-stagnation blood-aggregation type bedsore and preparation method thereof | |
CN104984070A (en) | Medicine for treating burns | |
CN104173750A (en) | Drug for scald | |
CN104800427A (en) | Burn and scald recovery application and preparation method thereof | |
CN104984280A (en) | Foot soaking decoction for treating exogenous wind-cold and preparation method thereof | |
CN110538277A (en) | Black ointment for treating lumbocrural pain and surgical infection | |
CN104258314A (en) | Traditional Chinese medicine composition for treating epidermis injury and preparation method thereof | |
CN111035708A (en) | Olive oil aloe burn cream | |
CN116617330A (en) | Ointment for repairing scalds and preparation method thereof | |
CN108969737A (en) | A kind of abdomen moxibustion composition and preparation method thereof for treating postpartum abdominal pain and dysmenorrhea | |
CN106310145A (en) | External use drug for treating haemorrhoids and preparation method thereof | |
CN107412686A (en) | A kind for the treatment of whelk Chinese medicine preparation containing motherwort | |
CN100400070C (en) | Externally applied medicine for treating dermatosis and preparation method thereof | |
CN105343381A (en) | Plaster for treating tenosynovitis and preparation method of plaster | |
CN105412416A (en) | Traditional Chinese medicine lotion for treating rheumatic arthritis and preparation method thereof | |
CN104984071A (en) | Burn and scald restoration medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211126 |